- PsA: Characteristics of Persistent Liver Abnormalities
- Psoriasis, but Not Use of Biologics, Tied to Cancer Risk
- SLE Risk Elevated in Women with PsA
- Migraine and Neuropathic Pain in Rheumatic Diseases: How Bad Is It?
- Inflammatory Arthritis: COVID-19 Outcomes in Patients on DMARDs
- In PsA, RA, and axSpA, Fatigue Hits Hard
- Psoriatic Arthritis and Sleep Problems, Fatigue, and Depression
- In Psoriasis, Be Alert to Impaired Hand Function—Even in the Absence of Arthritis
- When Psoriasis Patients Need a Rheumatology Referral-Yesterday
- Nail Disease in Psoriatic Arthritis
- Rheum Tweets During a Pandemic
- Which Psoriasis Characteristics Predict Psoriatic Arthritis?
- Psoriatic Arthritis, Even with Comorbidities, Does Not Increase Mortality Risk
- Inflammatory Rheumatic Diseases and Fatigue
- PsA and VTE: Untangling the Connection
- Methotrexate for Psoriatic Arthritis: When Patients Aren’t Compliant
- Psoriasis to PsA: What Drives the Transition?
- How Does COVID-19 Affect Outcomes in Patients with IMIDs?
- Patients with Autoimmune Inflammatory Rheumatic Diseases: Better COVID-19 Vaccinations Rates Needed
- Joint Involvement in Psoriasis: Increased Depression Burden
- Does Atopic Dermatitis Open a Window to Other Autoimmune Diseases?
- PsA and Obesity: Can Patients Lose Weight Without Muscle Deterioration?
- In PsA, Novel Potential Contributions to Coronary Artery Disease
- Predicting the Risk of PsA in Patients with Psoriasis
- Do Psoriasis Patients Have an Increased Risk of Suicide?
- Emerging Data on Isolated Axial Disease in PsA and Ankylosing Spondylitis with Psoriasis
- Does Inflammatory Joint Disease Increase Preeclampsia Risk?
- In PsA, Achieving Early Minimal Disease Activity May Improve Long-term Patient-Reported Outcomes
- Early PsA Diagnosis: Can Circulating MicroRNA Patterns Help?
- Cessation of Biologics in PsA: Is It Viable?
- Tools for Assessing Patients with PsA
- Imaging for Subclinical Signs of PsA
- Smoking and PsA: What’s the Real Story?
- Predicting Response to PsA Therapy: Beyond CRP?
- HLA B27: Does it Have a Role in PsA?
- Treatment Recommendations for PsA: Improving the Evidence
- Challenges of a Treat-to-Target Approach in PsA
- Q&A: Guy Katz, MD, on Inflammatory Arthritis and Depression, Anxiety, Pain, or Opioid Use and TNF Inhibitor Persistence
- Q&A: The Link Between Obesity and Psoriatic Arthritis
- Q&A: Distinguishing Psoriatic Arthritis